JPWO2020061007A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020061007A5
JPWO2020061007A5 JP2021514531A JP2021514531A JPWO2020061007A5 JP WO2020061007 A5 JPWO2020061007 A5 JP WO2020061007A5 JP 2021514531 A JP2021514531 A JP 2021514531A JP 2021514531 A JP2021514531 A JP 2021514531A JP WO2020061007 A5 JPWO2020061007 A5 JP WO2020061007A5
Authority
JP
Japan
Prior art keywords
composition
ligand
camptothecin
peg
camptothecin analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021514531A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022501341A (ja
JP7546552B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/051457 external-priority patent/WO2020061007A1/en
Publication of JP2022501341A publication Critical patent/JP2022501341A/ja
Publication of JPWO2020061007A5 publication Critical patent/JPWO2020061007A5/ja
Application granted granted Critical
Publication of JP7546552B2 publication Critical patent/JP7546552B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021514531A 2018-09-17 2019-09-17 ポリマーベースの高分子プロドラッグ Active JP7546552B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862732199P 2018-09-17 2018-09-17
US62/732,199 2018-09-17
PCT/US2019/051457 WO2020061007A1 (en) 2018-09-17 2019-09-17 Polymer-based macromolecular prodrugs

Publications (3)

Publication Number Publication Date
JP2022501341A JP2022501341A (ja) 2022-01-06
JPWO2020061007A5 true JPWO2020061007A5 (enExample) 2022-09-26
JP7546552B2 JP7546552B2 (ja) 2024-09-06

Family

ID=69887739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021514531A Active JP7546552B2 (ja) 2018-09-17 2019-09-17 ポリマーベースの高分子プロドラッグ

Country Status (10)

Country Link
US (4) US11253603B2 (enExample)
EP (1) EP3852793B1 (enExample)
JP (1) JP7546552B2 (enExample)
KR (1) KR20210072002A (enExample)
CN (2) CN112996533B (enExample)
AU (1) AU2019344783B2 (enExample)
CA (1) CA3112778A1 (enExample)
EA (1) EA202190799A1 (enExample)
MX (1) MX2021003116A (enExample)
WO (1) WO2020061007A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112996533B (zh) * 2018-09-17 2025-01-10 费城儿童医院 基于聚合物的大分子前药
CN115443947B (zh) * 2022-10-12 2023-11-21 江苏省人民医院（南京医科大学第一附属医院） 高血压动物模型的制备方法
WO2025101904A1 (en) * 2023-11-08 2025-05-15 The Children's Hospital Of Philadelphia Norepinephrine transporter-targeted prodrugs for cancer therapy

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052861A1 (de) * 1998-04-09 1999-10-21 Institut für Diagnostikforschung GmbH an der Freien Universität Berlin Neue benzylguanidinderivate für die therapie, in-vivo- und in-vitro-diagnostik
JP2002255821A (ja) * 2001-03-06 2002-09-11 Yakult Honsha Co Ltd 抗癌剤耐性癌に対する治療剤
US7591994B2 (en) * 2002-12-13 2009-09-22 Immunomedics, Inc. Camptothecin-binding moiety conjugates
US20040258754A1 (en) * 2003-06-18 2004-12-23 Valery Alakhov Compositions for oral administration of camptothecin and its analogs
KR101200729B1 (ko) 2003-09-17 2012-11-13 넥타르 테라퓨틱스 다분지형 고분자 전구약물
US8394365B2 (en) 2003-09-17 2013-03-12 Nektar Therapeutics Multi-arm polymer prodrugs
CA2543722C (en) * 2003-10-29 2011-01-04 Sonus Pharmaceuticals, Inc. Tocopherol-modified therapeutic drug compounds
WO2007106549A2 (en) * 2006-03-15 2007-09-20 Alza Corporation Method for treating brain cancer
CA2662973A1 (en) * 2006-09-15 2008-03-20 Enzon Pharmaceuticals, Inc. Lysine-based polymeric linkers
US20090074074A1 (en) 2007-06-29 2009-03-19 The Hong Kong University Of Science And Technology Multiple description encoder and decoder for transmitting multiple descriptions
CN102159250B (zh) * 2008-08-11 2014-08-06 尼克塔治疗公司 多臂的聚合烷酸酯偶联物
PT2349346T (pt) 2008-09-23 2019-10-24 Nektar Therapeutics Método de dosagem metronómica com profármacos de camptotecina (e.g. peg-irinotecano).
CN102215688A (zh) * 2008-10-21 2011-10-12 安龙制药公司 用7-乙基-10-羟基喜树碱的多臂聚合物对神经母细胞瘤的治疗
CN101385860B (zh) * 2008-10-31 2011-11-02 美国草药泉有限责任公司 喜树碱及其衍生物的非线性聚乙二醇前药
EP2456464A4 (en) 2009-07-22 2013-02-20 Enzon Pharmaceuticals Inc METHODS OF TREATING POSITIVE HER2 CANCER WITH HER2 RECEPTOR ANTAGONIST IN COMBINATION WITH 7-ETHYL-10-HYDROXYCAMPTOTHECIN MULTI-ARM POLYMERIC CONJUGATES
HUE043689T2 (hu) 2009-11-18 2019-09-30 Nektar Therapeutics Polimer-gyógyszer savas sói
WO2012083197A1 (en) 2010-12-17 2012-06-21 Nektar Therapeutics Water-soluble polymer conjugates of topotecan
CN102626518B (zh) * 2012-05-09 2014-05-28 中国药科大学 一种包载难溶性药物的泊洛沙姆/两亲性多糖混合胶束的制备和应用
CN104813167B (zh) 2012-11-28 2019-04-09 尼克塔治疗公司 用于评估和预测用一种长效拓扑异构酶i抑制剂进行乳腺癌治疗的疗效的方法
WO2014194289A1 (en) 2013-05-31 2014-12-04 Nektar Therapeutics Method for predicting and evaluating responsiveness to cancer treatment with dna-damaging chemotherapeutic agents
US10016411B2 (en) * 2013-10-04 2018-07-10 Prolynx Llc Slow-release conjugates of SN-38
WO2015191583A2 (en) 2014-06-09 2015-12-17 Biomed Valley Discoveries, Inc. Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase
WO2016040848A1 (en) 2014-09-12 2016-03-17 G1 Therapeutics, Inc. Treatment of rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors
WO2016050210A1 (zh) 2014-10-01 2016-04-07 厦门赛诺邦格生物科技有限公司 一种多官能化聚乙二醇衍生物及其制备方法
CN104877127B (zh) 2015-06-23 2017-11-10 厦门赛诺邦格生物科技股份有限公司 一种八臂聚乙二醇衍生物、制备方法及其修饰的生物相关物质
CN107375288B (zh) 2016-05-16 2019-08-23 博瑞生物医药（苏州）股份有限公司 多臂的聚合靶向抗癌偶联物
WO2018048859A1 (en) 2016-09-06 2018-03-15 Cerebral Therapeutics Direct brain administration of chemotherapeutics to the csf for patients with primary and secondary brain tumors
AU2018255458B2 (en) 2017-04-21 2020-06-25 Brightgene Bio-Medical Technology Co., Ltd. Multi-arm targeted anti-cancer conjugate
CN111328330B (zh) 2017-09-08 2024-03-08 普罗蒙托里治疗有限公司 作为免疫调节剂的磷铂化合物及其治疗用途
WO2019090141A1 (en) 2017-11-02 2019-05-09 Vicus Therapeutics, Llc Combination drug therapies for cancer and methods of making and using them
US20190375732A1 (en) 2018-05-14 2019-12-12 David Hung Anti-cancer nuclear hormone receptor-targeting compounds
CN112996533B (zh) * 2018-09-17 2025-01-10 费城儿童医院 基于聚合物的大分子前药
CN111603567B (zh) 2019-02-22 2024-12-27 赣江新区博瑞创新医药有限公司 Cd44靶向多臂偶联物
KR20220008869A (ko) 2019-05-14 2022-01-21 누베이션 바이오 인크. 항암 핵 호르몬 수용체-표적화 화합물

Similar Documents

Publication Publication Date Title
CN102037058B (zh) 多西紫杉醇高分子衍生物、及其制造方法及其用途
JP5249016B2 (ja) タキサン類の高分子結合体
JP2011528654A5 (enExample)
JP5856069B2 (ja) 新規なシチジン系代謝拮抗剤の高分子誘導体
JP2016528174A5 (enExample)
JP2003113113A5 (enExample)
KR101956444B1 (ko) 자가 조립 나노입자 방출형 용해성 마이크로니들 구조체 및 그 제조방법
JP2012503603A5 (enExample)
CN1268321C (zh) 内部包有药物的高分子胶束的冻结干燥用组合物和该胶束的制备方法
HK1040052B (zh) 药物复合物
CN103044437A (zh) 用于治疗肿瘤的两亲性缀合物纳米颗粒及制备方法、应用
JP2019507781A5 (enExample)
CN102634033A (zh) 葡聚糖基两亲性嵌段共聚物制备方法
Gillani et al. Synthesis, characterization and applications of poly-aliphatic amine dendrimers and dendrons
JP2019513868A5 (enExample)
US7511023B2 (en) Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof
JP2006525368A5 (enExample)
JP2006508912A5 (enExample)
JPWO2020061007A5 (enExample)
KR101874764B1 (ko) 음이온-양이온성 환형다당류 조성물인 벤다무스틴
JP2005526016A5 (enExample)
JP2025509728A (ja) ポリマーナノ凝集体医薬組成物およびその使用
JP2018530568A5 (enExample)
CN113563495B (zh) 一种1,4-二氢吡啶基壳聚糖的制备方法及其应用
JP6837962B2 (ja) 活性薬剤の送達のための両親媒性ブロックコポリマー